We also investigated whether oral acetate supplementation prevented the MC-LR induced pro-inflammatory phenotype leading to MASLD–like outcomes in adulthood and the mechanistic role of acetate-mediated attenuation of NLRP3 inflammasome activation. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.